期刊文献+

HGF、C-Met在子宫内膜异位症患者在位子宫内膜的表达及意义 被引量:1

Expression and significance of hepatocyte growth factor and C-Met in the eutopic endometrium of endometriosis
下载PDF
导出
摘要 目的:探讨肝细胞生长因子(H G F)及其受体(C-M et)与子宫内膜异位症发病机制的关系。方法:采用链霉素抗生物素蛋白-过氧化物酶(S-P)法检测45例(增生期20例,分泌期25例)盆腔子宫内膜异位症及30例(增生期12例,分泌期18例非子宫内膜异位症妇女的在位子宫内膜的H G F与C-M et的免疫表达水平。结果:(1)盆腔子)宫内膜异位症的在位子宫内膜的H G F、C-M et表达水平显著增高P=0.006,P=0.001)。(2)H G F与C-M et呈正相(关(异位症及对照组r均为0.945)。(3)H G F与C-M et均随月经发生周期性变化(分泌期高于增生期,对照组H G F、C-M et分别为P=0.015、P=0.023;内异症组H G F、C-M et分别为P=0.003、P=0.015)。结论:类似肿瘤转移和浸润机制,H G F/C-M et系统可能参与了子宫内膜异位症的发病。 Objective To investigate the expression of hepatocyte growth factor (HGF) and C Met in the eutopic endometrium of pelvic endometriosis and the relationship between HGF and C Met in the pathogenesis of endometriosis. Methods The expression of HGF and C Met in the eutopic endometrium of forty five women with pelvic endometriosis(proliferative phase:n=20, secretory phase:n=25)and thirty women without endometriosis(proliferative phase:n=12,secretory phase:n=18)were detected with streptavidin peroxidase(S P) immunohistochemical method. Results (1)The expression of HGF and C Met were markedly higher in the eutopic endometrium of patients with pelvic endometriosis than in that of controls (P=0.006, P=0.001, respectively).(2)There had a positive correlation between the expression of HGF and C Met both in endometriosis and in without endometriosis (r=0.945).(3)We also found a significant correlation of HGF and C Met with menstrual cycle(proliferative was higher than secretory. HGF &C Met of control:P=0.015, P=0.023, respectively. HGF &C Met of endometriosis:P=0.003, P=0.015). Conclusion Analogous to tumor metastasis and invasive mechanism, HGF and C Met may be involved in the pathogenesis of endometriosis.
出处 《实用医学杂志》 CAS 2005年第8期797-799,共3页 The Journal of Practical Medicine
  • 相关文献

参考文献1

二级参考文献12

  • 1GiudiceLC, TazukeSI, SwierszL.Status ofcurrent research on endometriosis[J]. J Reprod Med, 1998, 43 (Suppl): 252-62.
  • 2Sampson JA. Heterotropic or misplaced endometrial tissue [J]. Am J Obstet Gynecol,1925, 10: 649-68.
  • 3Ewa Barcz, Pawel Kaminski, Longin Marianowski. Role ofcytokines in pathogenesis ofendometriosis [J]. Med Sci Monit, 2000, 6(5):1042-6.
  • 4Sugawara J, Fukaya T, Murakami T, et al. Increased secretion of hepatocyte growthfactor by eutopic endometrial stromal cells in women with endometriosis[J]. Fertil Steril,1997, 68(3): 468-72.
  • 5Sezer O, Jakob C, Eucker J, et al. Serum levels of the angiogenic cytokines basicfibroblast growth factor (bFGF), vascular endothelial growth factor (VEGF) and hepatocytegrowth factor (HGF)inmultiple myeloma[ J ]. Eur J Haematol, 2000, 66(2): 83-8.
  • 6Sugawara J, Fukaya T, Murakami T, et al. Hepatocyte growth factor stimulatedproliferation, migration, and lumen formation of human endometrial epithelial cells invitro[J]. Biol Reprod, 1997, 57(4):936-42.
  • 7Thomas EJ, Campbell IG. Evidence that endometriosis behaves in a malignantmanner[J]. Gynecol Obstet Invest, 2000, 50(Suppl 1): 2-10.
  • 8Taylor RN, Lebovic DI, Mueller MD. Angiogenic factor in endometriosis[J]. Ann N YACad Sci, 2002, 955: 89-100.
  • 9Xin X, Yang S, Ingle G, et al. Hepatocyte growth factor enhances vascularendothelial growth factor-induced angiogenesis in vitro and in vivo[J]. Am J Pathol, 2001,158(3): 1111-20.
  • 10Khan KN, Masuzaki H, Fujishita A, et al. Association of interleukin-6 andestradiol with hepatocyte growth factor in peritoneal fluid of women with endometriosis[J]. Acta Obstet Gynecol Scand,2002, 81(8): 764-771.

共引文献11

同被引文献23

  • 1[2]Nakamura T.Structure and function of hepatocytegrowth factor[J].Prog Growth Factor Res,1991,3(1):67.
  • 2[3]Bottaro D,Rubin J,Faletto D,et al.Identification of the hepatocytegrowth factor receptor as the C-met proto-oncogene product[J].Science,1991,251:802.
  • 3[4]Vander R,Taher T,Derksen P,et al.The hepatocytegrowth factor/Met pathway indevelopment,tumorigenesis,and B-cell differentiation[J].Adv Cancer Res,2000,79(1):39.
  • 4[5]Stuart K,Riordan S,Lidder S,et al.Hepatocytegrowth factor/scatter factor induced intracellular signaling[J].Int J Exp Pathol,2000,81(1):17.
  • 5[6]Di-Renzo MF,Narsimhan RP,Olivero M,et al.Expression of the Met/HGF receptor in normal and neoplastic human tissues[J].Oncogene,1997,6(110:1007.
  • 6[7]Sugawara J,Fukaya T,M urakami,et al.Hepatocytegrowth factor stimulated proliferation,migration and lumen formation of human erdometrial epithelial cells in vitro[J].Biol Reprod,1997,57(4):936-942.
  • 7[9]Negami A,Sasaki H,Kawakami Y,et al.Serum human hepatocytegrowth factor in human menstrual cycle and pregnancy:a novel serum marker of regeneralion and reconstruction of human endometrium[J].Horm Res,1995,44 (Supp1 2):42.
  • 8[10]Sugawara J,Fukaya T,Murakami T,et al.Hepatocytegrowth factor stimulates proliferation,migration and lumen formation of human endometrial epithelial cells in vitro[J].Biol Reprod,1997,57:936 -42.
  • 9[11]Yoshida S,Harada T,Mitsunari M,et al.Hepatocytegrowth factor/Met system promotes endometrial and endometriotic stromal cell invasion via autocrine and paracrine pathways[J].Clin Endocrinol Metab,2004,89(2):823.
  • 10[12]Khan KN,Nagasaki U.Peritoneal fluid and serum levels of hepatocytegowth factor may predict the activity of endometriosis[J].Acta Obstetricia etgynecologica Scandinavica,2006,85 (4):458.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部